Results 11 to 20 of about 926,443 (292)
SARS‐CoV‐2 and hypertension [PDF]
Physiological Reports, 2021 The objective of this review is to give an overview of the pathophysiological effects of the Coronavirus Disease 2019 (COVID‐19) in relation to hypertension (HT), with a focus on the Renin–Angiotensin–Aldosterone System (RAAS) and the MAS receptor. HT is
Briyanth Ravichandran +5 more
doaj +4 more sources
SARS‐CoV‐2 and myasthenia [PDF]
Journal of Medical Virology, 2021 The COVID-19 pandemic due to infection with SARS-CoV-2 not only affects political, economic, social, and cultural life, but also has a significant impact on medicine. This article is protected by copyright. All rights reserved.
Finsterer, Josef +3 more
openaire +2 more sources
Epidemiology of SARS-CoV-2 [PDF]
Infection, 2020 Abstract Purpose SARS-CoV-2 is a recently emerged ß-coronavirus. Here we present the current knowledge on its epidemiologic features. Methods Non-systematic review.
Salzberger, Bernd +7 more
openaire +3 more sources
There is no “origin” to SARS-CoV-2
Environmental Research, 2022 Since the beginning of the COVID-19 pandemic in 2020 caused by SARS-CoV-2, the question of the origin of this virus has been a highly debated issue. Debates have been, and are still, very disputed and often violent between the two main hypotheses: a natural origin through the "spillover" model or a laboratory-leak origin.
Frutos, Roger +3 more
openaire +5 more sources
Cell Host & Microbe, 2021 A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss ...
Bogunovic, Dusan, Merad, Miriam
openaire +2 more sources
Immunological Medicine, 2022 SARS-CoV-2 virus has become a global health problem that has caused millions of deaths worldwide. The infection can present with multiple clinical features ranging from asymptomatic or mildly symptomatic patients to patients with severe or critical illness that can even lead to death.
Dennis Jiménez, Marbel Torres Arias
openaire +3 more sources
Infectious Disease Clinics of North America, 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020 and has led to an unprecedented global pandemic. Understanding the virology behind SARS-CoV-2 infection has provided key insights into our efforts to develop antiviral agents and control the COVID-19 pandemic.
Li, Yijia, Li, Jonathan Z.
openaire +3 more sources
2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission. [PDF]
, 2020 With the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in coronavirus disease 2019 (COVID-19), corporate entities, federal, state, county, and city governments, universities, school districts, places of worship,
Coil, David A +5 more
core +2 more sources
Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal [PDF]
, 2020 Funding This study is co-funded by Fundação para a Ciência e a Tecnologia and Agência de Investigação Clínica e Inovação Biomédica [grant number 234_596874175] on behalf of the Research 4 COVID-19 call. This work is also a result of the GenomePT project [
Portuguese network for SARS-CoV-2 genomics
core +1 more source
SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal [PDF]
, 2022 © The Author(s) 2022.BACKGROUND: Genomic surveillance of SARS-CoV-2 in Portugal was rapidly implemented by the National Institute of Health in the early stages of the COVID-19 epidemic, in collaboration with more than 50 laboratories distributed ...
Portuguese network for SARS-CoV-2 genomics (Consortium)
core +1 more source